文献速递MDS 与骨髓增殖性肿瘤

循环游离DNA提升Ph阴性骨髓增殖性肿瘤的分子特征描述

Circulating cell-free DNA improves the molecular characterisation of Ph-negative myeloproliferative neoplasms.
PubMed 文献 · Br J Haematol · 2020-09-18

该研究对107例Ph阴性MPN患者(33例PV、56例ET、14例PMF、4例不可分类MPN)采用cfDNA与配对粒细胞DNA进行NGS检测。cfDNA靶向测序与粒细胞DNA的突变谱一致(准确率100%),且cfDNA检出的中位VAF显著高于粒细胞DNA。结论支持cfDNA作为快速、灵敏、准确的MPN分子特征描述策略。

要点

  • cfDNA与粒细胞DNA的突变谱一致,准确率达100%。

核心结论

  • cfDNA可用于MPN患者快速、灵敏、准确的分子特征描述。

研究设计与样本

  • 研究纳入107例Ph阴性MPN患者,包括33例PV、56例ET、14例PMF和4例不可分类MPN。
  • 采用NGS检测cfDNA与配对粒细胞DNA的分子谱。

主要发现

  • cfDNA靶向测序与粒细胞DNA的突变谱一致,准确率为100%。
  • 两种DNA来源的基因突变VAF呈强相关。
  • 高分子复杂度、MPL突变及PMF患者血浆cfDNA浓度高。

临床怎么用

  • 可考虑用cfDNA液体活检替代或补充粒细胞DNA进行MPN分子检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Genetic studies in patients with Philadelphia-negative myeloproliferative neoplasms (MPNs) are essential to establish the correct diagnosis and to optimise their management. Recently, it has been demonstrated that it is possible to detect molecular alterations analysing cell-free DNA (cfDNA) in plasma samples, which is known as liquid biopsy. We have assessed the molecular profile of a cohort of 107 MPN patients [33 polycythaemia vera (PV), 56 essential thrombocythaemia (ET), 14 primary myelofibrosis (PMF) and 4 unclassifiable MPN] by next-generation sequencing (NGS) using cfDNA and paired granulocyte DNA. A high concentration of cfDNA in plasma was observed in patients with high molecular complexity, in MPL-mutated cases, and in PMF patients. Targeted sequencing of cfDNA showed a comparable mutational profile (100% accuracy) to the one obtained in granulocytic DNA and a strong correlation was observed between the variant allele frequency (VAF) of gene mutations in both DNA sources. The median VAF detected in cfDNA (29·0%; range: 0·95-91·73%) was significantly higher than the VAF detected in granulocytes (median 25·2%; range: 0·10-95·5%), especially for MPL mutations (44·3% vs. 22·5%). In conclusion, our data support the use of cfDNA as a fast, sensitive and accurate strategy for performing molecular characterisation of MPN patients.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Garcia-Gisbert N, Fernández-Ibarrondo L, Fernández-Rodríguez C, et al. Circulating cell-free DNA improves the molecular characterisation of Ph-negative myeloproliferative neoplasms. Br J Haematol. 2020. PMID: 32945548. doi:10.1111/bjh.17087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。